Scarless robotic thyroid surgery is now available in Georgia as American Endocrine expands access to advanced minimally ...
Baseline FT3 and TRAb levels were key prognostic markers for achieving remission in pediatric patients with Graves orbitopathy (GO).
Phase 3 trial results show combined ixekizumab and tirzepatide therapy outperforms ixekizumab alone for patients with psoriasis and obesity or overweight.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results